Microvascular protection with calcium dobesilate (Doxium) in diabetic retinopathy.
D000328:Adult; D000368:Aged; D001557:Benzenesulfonates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D006873:Hydroquinones / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010539:Permeability; D010919:Placebos; D013997:Time Factors
D001557:Benzenesulfonates; D006490:Hemostatics; D006873:Hydroquinones; D010919:Placebos